MAYO CLINIC FLORIDA
The Sunshine Act requires manufacturers to report payments to teaching hospitals as institutions, separately from payments to individual physicians. These figures are money reported to the hospital itself — most of it research funding and grants, not compensation to any named doctor.
- Total reported
- $17.7M
- Transactions
- 2,065
- Companies
- 40
- Average per transaction
- $8,574
Who reported the payments
| Merck | $3,680,368 |
| Pharmacyclics LLC, An Abbvie Company | $1,910,470 |
| Novartis | $1,496,500 |
| Pfizer | $825,350 |
| Takeda Pharmaceuticals U.S.A., Inc. | $736,923 |
| Servier Bioinnovation | $724,494 |
| Jazz Pharmaceuticals Inc. | $713,547 |
| Incyte Corporation | $685,520 |
| Daiichi Sankyo Inc. | $676,559 |
| Eli Lilly | $661,390 |
| Siemens Medical Solutions USA, Inc. | $661,188 |
| Tesaro, Inc. | $326,471 |
| Insmed, Inc. | $316,266 |
| Blue Earth Diagnostics | $269,877 |
| AbbVie | $267,976 |
| Acutus Medical, Inc. | $259,000 |
| Transmedics, Inc. | $258,789 |
| Stryker | $230,864 |
| Exactech, Inc. | $222,796 |
| Boehringer Ingelheim | $178,397 |
| Carl Zeiss Meditec, Inc. | $167,003 |
| UCB SA | $136,938 |
| Bristol Myers Squibb | $127,274 |
| Medtronic | $125,869 |
| UCB, Inc. | $121,000 |
| Getinge USA Sales, LLC | $105,000 |
| Stemline Therapeutics Inc. | $103,605 |
| AstraZeneca | $101,694 |
| Amgen | $100,321 |
| Sanofi-aventis U.S. LLC | $79,867 |
| Zimmer Biomet | $72,599 |
| Xvivo Perfusion Inc. | $72,435 |
| Arthrex | $64,158 |
| GSK | $62,856 |
| Puma Biotechnology, Inc. | $58,988 |
| Agios Pharmaceuticals, Inc. | $54,800 |
| Sanofi | $50,420 |
| ICU Medical Inc | $45,277 |
| Angiodynamics, Inc. | $44,874 |
| Alnylam Pharmaceuticals Inc. | $42,065 |